Michael C. Gorry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michael C. Gorry has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Adrian V. Lee
University of Pittsburgh
14 shared publications - Daniel D. Brown
Institute for Precision Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
14 shared publications - Henrik J. Ditzel
University of Southern Denmark
14 shared publications - Laurits R. Sloth
Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense M, Denmark
14 shared publications - Maria Stahl Madsen
Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark
14 shared publications - Mikkel Green Terp
Department of Molecular Medicine, Cancer Research Unit, University of Southern Denmark, Odense M, Denmark
14 shared publications
Latest Publications
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
BRG1, but not BRM, is overexpressed in TNBC.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
BRG1, but not BRM, is overexpressed in TNBC.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
Processed qPLEX-RIME data for Fig. 1A.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
Processed qPLEX-RIME data for Fig. 1A.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
GATA6 is not required for the transcriptional response to DEX.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
GATA6 is not required for the transcriptional response to DEX.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
Processed qPLEX-RIME data for Fig. 1C.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
Processed qPLEX-RIME data for Fig. 1C.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
Processed RNA-seq data for Fig. 2C.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
Processed RNA-seq data for Fig. 2C.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
BRM014 represses cell proliferation and DEX-induced chemoresistance.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
BRM014 represses cell proliferation and DEX-induced chemoresistance.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
Processed RNA-seq data for Fig. 5A.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
Processed RNA-seq data for Fig. 5A.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
BRM014 specifically inhibits BRG1/BRM function.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
BRM014 specifically inhibits BRG1/BRM function.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
BRM014 decommissions enhancers bound by Fra-1/c-Jun.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
BRM014 decommissions enhancers bound by Fra-1/c-Jun.